|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61K 39/00 | (2006.01) | ||
| C07K 7/06 | (2006.01) | ||
| C07K 7/08 | (2006.01) | ||
| G01N 33/50 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2923708 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15154344.4 |
| Date of filing the European patent application | 2011-03-15 | |
| (97) | Date of publication of the European application | 2015-09-30 |
| (45) | Date of publication and mention of the grant of the patent | 2017-07-12 |
| (46) | Date of publication of the claims translation | 2017-10-10 |
| (30) | Number | Date | Country code |
| 315704 P | 2010-03-19 | US | |
| 201004551 | 2010-03-19 | GB |
| (72) |
Weinschenk, Toni, DE
Fritsche, Jens, DE
Walter, Steffen, DE
Lewandrowski, Peter, DE
Singh, Harpreet, DE
|
| (73) |
Immatics Biotechnologies GmbH,
Paul-Ehrlich-Strasse 15, 72076 Tübingen,
DE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Nauja imunoterapija navikams, įskaitant virškinimo trakto ir skrandžio vėžį, gydyti |
| Novel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| Payment date | Validity (years) | Amount | |
| 2024-03-05 | 14 | 289.00 EUR |
| 2025-03-15 |